Auden Mckenzie (Pharma Division) Ltd. and Accord-UK Ltd.
Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd.
In 2015 Auden McKenzie was acquired by Actavis PLC, which sold its generics business in 2016 to Teva Pharmaceuticals, which sold its UK generics business to Accord Healthcare, a subsidiary of Intas Pharmaceuticals, in 2017.
2882238
2020
20200304
competition-related offences
Warning: Undefined array key "offence_type" in /usr/home/goodjobsfirst/public_html/Live-UK-ViolationTracker/function.php on line 348
Auden Mckenzie and Accord-UK agreed to pay a £1,882,228 fine and make a payment of £1,000,000 to the NHS in settlement of a decision by the CMA that the companies had illegally colluded with King, another supplier of the drug nortriptyline, to fix prices and supply. King also paid a fine in settlement of the decision.
agency action
Settlement with the CMA
50507
UK-CMA
Competition and Markets Authority
India
privately held
pharmaceuticals
pharmaceuticals
https://www.gov.uk/cma-cases/pharmaceutical-sector-suspected-anti-competitive-agreements-and-conduct-50507-2
UK21-214
Actavis UK Ltd.
Intas Pharmaceuticals Ltd.
Actavis PLC
Actavis PLC had acquired Allergan Inc. and changed name to Allergan PLC in 2015. Later in 2016 they sold Actavis UK Ltd. to Teva Pharmaceutical Industries, which sold Actavis UK to Accord Healthcare, a subsidiary of Intas Pharmaceuticals, in 2017.
1542860
2016
20160212
competition-related offences
Warning: Undefined array key "offence_type" in /usr/home/goodjobsfirst/public_html/Live-UK-ViolationTracker/function.php on line 348
Actavis UK Limited (formerly Alpharma Limited) was fined £1,542,860 in a decision by the CMA that the company accepted money from GlaxoSmithKline to delay entry into the UK market with the generic drug paroxetine (allowing GSKs branded version Seroxat to dominate the market at a higher price), in breach of competition law.
agency action
UK-CMA
Competition and Markets Authority
India
privately held
pharmaceuticals
pharmaceuticals
https://www.gov.uk/cma-cases/investigation-into-agreements-in-the-pharmaceutical-sector
UK21-355
Auden Mckenzie and Actavis UK
Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd.
In 2015 Auden McKenzie was acquired by Actavis PLC, which sold its generics business in 2016 to Teva Pharmaceuticals, which sold its UK generics business to Accord Healthcare, a subsidiary of Intas Pharmaceuticals, in 2017.
130000000
2023
20230918
competition-related offences
Warning: Undefined array key "offence_type" in /usr/home/goodjobsfirst/public_html/Live-UK-ViolationTracker/function.php on line 348
The Competition Appeal Tribunal upheld a finding by the Competition and Markets Authority that Auden/Actavis UK abused a dominant market position to increase the price of hydrocortisone tablets over a decade by over 10,000%, imposing a fine of about £130 million.
UK-CMA
Competition and Markets Authority
India
privately held
pharmaceuticals
pharmaceuticals
https://www.gov.uk/government/news/cma-decision-upheld-in-major-drug-price-abuse-case
UK21-96219
3